Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Morris

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
Alzheimer Disease and Associated Disorders|January 1, 1997
Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesH Feldman, R Anand, R Blesa, et al.
Endocrinology|March 1, 1994
Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and functionJ S Dallas, R K Desai, S J Cunningham, et al.
Alzheimer Disease and Associated Disorders|September 15, 1999
Clinical trials in Alzheimer disease: debate on the use of placebo controlsC H Kawas, C M Clark, M R Farlow, et al.
Gene Therapy|February 28, 2014
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancerJ C Morris, C A Ramlogan-Steel, P Yu, et al.
Neurology|January 14, 2004
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled studyS A Reines, G A Block, J C Morris, et al.
Endocrinology|August 1, 1996
Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH bindingJ S Dallas, S J Cunningham, S A Patibandla, et al.
Cancer Research|May 8, 1999
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell linesC Spitzweg, S Zhang, E R Bergert, et al.
Archives of Neurology|December 26, 2001
Current concepts in mild cognitive impairmentR C Petersen, R Doody, A Kurz, et al.
The Journal of Endocrinology|December 10, 1999
Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancerM R Castro, E R Bergert, T G Beito, et al.
Archives of General Psychiatry|December 15, 2000
Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosisN B Farber, E H Rubin, J W Newcomer, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
Alzheimer Disease and Associated Disorders|January 1, 1997
Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug GuidelinesH Feldman, R Anand, R Blesa, et al.
Endocrinology|March 1, 1994
Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and functionJ S Dallas, R K Desai, S J Cunningham, et al.
Alzheimer Disease and Associated Disorders|September 15, 1999
Clinical trials in Alzheimer disease: debate on the use of placebo controlsC H Kawas, C M Clark, M R Farlow, et al.
Gene Therapy|February 28, 2014
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancerJ C Morris, C A Ramlogan-Steel, P Yu, et al.
Neurology|January 14, 2004
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled studyS A Reines, G A Block, J C Morris, et al.
Endocrinology|August 1, 1996
Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH bindingJ S Dallas, S J Cunningham, S A Patibandla, et al.
Cancer Research|May 8, 1999
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell linesC Spitzweg, S Zhang, E R Bergert, et al.
Archives of Neurology|December 26, 2001
Current concepts in mild cognitive impairmentR C Petersen, R Doody, A Kurz, et al.
The Journal of Endocrinology|December 10, 1999
Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancerM R Castro, E R Bergert, T G Beito, et al.
Archives of General Psychiatry|December 15, 2000
Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosisN B Farber, E H Rubin, J W Newcomer, et al.
Pageof 34